Last updated on February 2020

Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza

Brief description of study

This study will evaluate the efficacy, safety, and pharmacokinetics of baloxavir marboxil in combination with a standard-of-care (SOC) neuraminidase inhibitor (NAI) (i.e., oseltamivir, zanamivir, or peramivir) compared with a matching placebo in combination with a SOC NAI in hospitalized patients with influenza.

Clinical Study Identifier: NCT03684044

Find a site near you

Start Over

Northwestern University

Chicago, IL United States
  Connect »

Barnum Medical Research, Inc.

Natchitoches, LA United States
  Connect »

Detroit Receiving Hospital

Detroit, MI United States
  Connect »

Marshfield Clinic

Marshfield, WI United States
  Connect »

Hospital Rawson

Cordoba, Argentina
  Connect »

Sanatorio del Oeste

Ituzaingo, Argentina
  Connect »

Flinders Medical Centre

Bedford Park, Australia
  Connect »

Geelong Hospital

Geelong, Australia
  Connect »

UZ Leuven

Leuven, Belgium
  Connect »

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »

Prince of Wales Hospital

Shatin, New Territories, Hong Kong
  Connect »

Fujita General Hospital

Dategun Kunimimachi, Japan
  Connect »

Korea University Ansan Hospital

Gyeonggi-do, Korea, Republic of
  Connect »

Jeroen Bosch Ziekenhuis

'S Hertogenbosch, Netherlands
  Connect »

Ikazia Ziekenhuis

Rotterdam, Netherlands
  Connect »

Isala Klinieken

Zwolle, Netherlands
  Connect »

Tauranga Hospital

Tauranga, New Zealand
  Connect »

Wellington Hospital

Wellington, New Zealand
  Connect »

Clinica Mayo de U.M.C.B. S.R.L

San Miguel de Tucumán, Argentina
  Connect »